Jason R. Williams, MD, DABR

Ablative technology may generate an immune response that can be enhanced via injected immunotherapy in patients with solid tumors.

Performing ablation and injecting tumor sites with immunotherapy may be “synergistic”, according to Jason R. Williams, MD, DABR.